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Abstract
Background: In hepatocellular carcinoma (HCC) genes predictive of survival have been found in both adjacent normal (AN)
and tumor (TU) tissues. The relationships between these two sets of predictive genes and the general process of
tumorigenesis and disease progression remains unclear.
Methodology/Principal Findings: Here we have investigated HCC tumorigenesis by comparing gene expression, DNA copy
number variation and survival using ,250 AN and TU samples representing, respectively, the pre-cancer state, and the
result of tumorigenesis. Genes that participate in tumorigenesis were defined using a gene-gene correlation meta-analysis
procedure that compared AN versus TU tissues. Genes predictive of survival in AN (AN-survival genes) were found to be
enriched in the differential gene-gene correlation gene set indicating that they directly participate in the process of
tumorigenesis. Additionally the AN-survival genes were mostly not predictive after tumorigenesis in TU tissue and this
transition was associated with and could largely be explained by the effect of somatic DNA copy number variation (sCNV) in
cis and in trans. The data was consistent with the variance of AN-survival genes being rate-limiting steps in tumorigenesis
and this was confirmed using a treatment that promotes HCC tumorigenesis that selectively altered AN-survival genes and
genes differentially correlated between AN and TU.
Conclusions/Significance: This suggests that the process of tumor evolution involves rate-limiting steps related to the
background from which the tumor evolved where these were frequently predictive of clinical outcome. Additionally
treatments that alter the likelihood of tumorigenesis occurring may act by altering AN-survival genes, suggesting that the
process can be manipulated. Further sCNV explains a substantial fraction of tumor specific expression and may therefore be
a causal driver of tumor evolution in HCC and perhaps many solid tumor types.
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Introduction
A universal feature of cancer cells is genomic instability
[1,2,3,4,5], which is thought to be required to generate sufficient
variability from which advantageous changes for tumor growth
and survival are selected [6]. Following this paradigm, it is now
understood that genomic instability can arise from defects in DNA
synthesis and repair, chromosome segregation, checkpoints,
telomere loss and other biological processes that result in point
mutations, copy number variation and gain/loss of biological
functions [2,3,4,7,8,9,10]. Hepatocellular carcinoma (HCC) is the
second most prevalent cancer of Asian populations and the third
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e20090leading cause of cancer death in the world. Currently the only
effective treatment option is surgery [11]. HCC commonly arises
in patients with viral hepatitis and/or cirrhosis where extensive
inflammation exposes hepatocytes to mitogenic stimuli [11]. The
pre-neoplastic phase is characterized by a number of changes,
including the emergence of telomere shortening and the
appearance of genomic alterations [12]. Structural changes in
the genome progressively accumulate during the transition to
neoplasia and from early to late stage HCC [11]. Genomic
alterations in HCC are heterogeneous in that many loci have been
reported to be altered but generally at a low prevalence [12]. This
leads to the hypothesis that there are alternate perturbations that
promote tumorigenesis in HCC [11,12].
Integrative genomics analysis has been successfully applied to
many non-cancer diseases [13,14] and has described networks of
gene variation by testing all possible associations across diverse
populations segregating the disease of interest. This work has
established that genes are generally part of coherent networks, and
that the most significant associations of genes to disease often
occur in the context of network sub-regions where many or all
members of these sub-networks are associated with each other and
with disease traits [13,15,16]. Such sub-networks have further
been associated with DNA variation and validated as causally
driving disease outcome [13].
Here we have examined gene network structure using a
collection of ,250 matched tumor (TU) and adjacent normal
(AN) samples removed from HCC patients during surgical
resection and have assessed whether these networks are associated
with DNA and disease variation in the HCC cohort. The
approach was in essence to uncover interactions within and
between the data types measured in this population (DNA,
expression, survival) in AN and TU tissues in an open ended,
comprehensive and completely data driven manner. The interac-
tions characteristic of tumors (TU) were compared to normal (AN)
tissue to reveal tumor specific changes. Here we present the results
of that comprehensive analysis and show that sCNV robustly alters
the expression of a large number of genes and also the relationship
of those genes to survival in either AN or TU tissue, and that
tumorigenesis largely involves disruption of normal functions and
the activation of a smaller set of functions that may be critical to
disease progression. The data suggested that genes predictive of
survival in AN tissue may be rate limiting steps for tumorigenesis.
Consistent with this hypothesis a treatment that induces HCC
tumorigenesis in mice, MET oncogene overexpression, was found
to selectively alter the expression of genes predictive of survival in
AN tissue of humans.
Results
To characterize gene networks in human liver tumor and
adjacent normal tissues we compiled a tissue specific cohort
comprised of liver tumor (TU) and adjacent normal (AN) tissues
from 272 Asian subjects (including 151 paired TU and AN
samples, Supplementary Table S1 [17]) undergoing surgical
resection for treatment of HCC. RNA was isolated from all TU
and AN samples and profiled on a custom Affymetrix
microarray comprised of oligonucleotide probes targeting
transcripts representing 37,585 known and predicted genes,
including high-confidence non-coding RNA sequences. DNA
was isolated from all AN and TU tissues and genotyped on the
Illumina 650Y SNP genotyping array. Copy number aberration
markers (sCNV markers) were then imputed for 32,711
locations in the genome from this high-density SNP panel
(Methods).
Gene networks in liver tumor and adjacent normal
samples
Given the large scale genomic changes generally known to
occur in tumor samples, our observation of large-scale expression
differences between the AN and TU samples in the HCC cohort
was not surprising, with 28,233 (.75%) of the 37,585 genes
represented on the microarray used in this study detected as
differentially expressed (p,0.05, FDR 0.07, see Table S2),
consistent with previous reports [18]. The main problem then in
interpreting molecular state changes between AN and TU is
distinguishing between those changes that are relevant to the
progression of the tumor from those changes that are simply
tracking with the genomic changes but not relevant to the tumor
biology. Therefore, we sought to characterize the impact these
large-scale changes had on the connectivity structure of the tissue-
specific gene networks, providing a path to identifying those
changes that lead to changes in the molecular networks that define
the biological processes carried out by the tissue.
To characterize changes between the AN and TU networks we
used a meta-analysis procedure [19,20] to test whether the
magnitude of association between any given pair of genes in one
tissue was significantly different from the association observed for
that same pair in the second tissue (Methods). Significant
correlation differences indicate the presence of connectivity
differences between the AN and TU networks (Figure 1). At a
Bonferroni adjusted, differential connectivity p=7e-11 (,,1%
family-wise error rate), we identified 1,156,638 differentially
correlated pairs (only 2 would have been expected by chance),
or roughly 12% of the 9,976,814 correlated gene pairs found in
either the AN or TU tissues. We also empirically estimated the
differential connectivity null distribution and observed no
differentially connected pairs with p,7e-11 (Figure 1), suggesting
that this degree of differential connectivity is highly significant.
To increase confidence that gene pairs identified as differen-
tially correlated between the AN and TU networks reflected
biologically relevant changes in network states related to
tumorigenesis and tumor progression, we restricted attention to
those differentially correlated gene pairs that were highly unlikely
to have occurred by chance (p,1e-19, with a mean change in
Spearman correlation coefficient between tissues of 0.73; no gene
pairs observed in the permuted data, FDR,1e-6, see Figure 1).
At this stringent cut-off, we identified 49,300 gene pairs covering
8,736 genes whose relationship differed significantly between the
TU and AN tissues. Of the 49,300 differentially connected pairs
identified, 42,179 (86%) were strongly correlated in the AN
tissues, but significantly less correlated in the TU tissues, while
only 7,121 pairs (14%) had stronger correlations in the TU versus
AN samples, indicating that the network changes occurring in the
tumor were more likely to destroy rather than create strong
associations between expression traits.
To distinguish between the types of genes involved in
differential connections we defined gain of connectivity (GOC)
genes as those in which more than 90% of their differential
interactions reflected correlations that were stronger in TU
compared to AN. Similarly, we defined loss of connectivity
(LOC) genes as those in which more than 90% of their differential
interactions reflected correlations that were weaker in TU
compared to AN (Supplementary Table S2). Although these are
arbitrary cut-offs they serve to highlight the relative distribution of
gain and loss of connectivity associated with tumorigenesis, given
greater than 80% of the differentially connected genes fall in one
of the two categories. Under this categorization there were 6,053
LOC genes and only 1,020 GOC genes. GO enrichment analysis
after Bonferroni correction for the number of categories revealed
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enriched, p=1.6e-20) and related processes (e.g., chromosome
segregation, DNA replication, and spindle organization), while the
LOC genes were mostly enriched for metabolic processes (1.11
fold enriched, p=1.4e-20), especially those associated with
mitochondria (1.56-fold enriched, p=1.5e-20). These results
suggest that the process of tumorigenesis is to a large degree one
of disruption of normal networks (LOC), and to a lesser degree one
of creation of new networks (GOC). Consistent with this, LOC
events were enriched for normal liver function genes, where as the
GOC events were enriched for genes involved in cancerous
growth of the cell. GOC events, although smaller in number, may
represent tumor specific functions required for disease progression
and as such may be an interesting source of targets for HCC. To
illustrate the nature of the differential connections the top 5 genes
and the genes to which they were differentially connected are
shown in Figure 2. Examples of individual gene pairs that were
differentially connected in TU or AN tissues are shown in Figure 3,
including the inhibitor of the G1 to S phase transition (CDKN2C
with loss of connectivity) and DNA replication licensing factor
(CDT1 showing gain of connectivity).
To assess whether the differential correlations were randomly
distributed amongst the significant gene-gene correlations or
whether there was some higher level structure, we examined the
distribution of the number of differential correlations for each
gene. We observed that whereas most genes participated in a small
number of differential correlations, there was a subset of genes that
participated in many differential correlations. In fact, the
differential correlations closely followed a power law distribution
that was quite different from what would be expected by chance
(see Figure 3). This indicates that certain genes represent hub
nodes in the differentially connected matrix that arose from
tumorigenesis and as such may be of particular importance.
sCNV explains a large fraction of TU expression variation
Given the large scale changes in expression and correlation
structures arose during the process of tumorigenesis, we sought to
identify the causal drivers of these changes. Somatic copy number
variation is a common feature of many solid tumor types and has
been associated with the aggressiveness of disease. For HCC in
particular sCNV has been observed at the earliest stages of disease
and increases in prevalence with disease progression [11]. We
therefore assessed the prevalence of sCNV in HCC and to what
extent it was associated with gene variation in the TU tissue.
DNA variation was assessed in the AN and TU samples using
Illumina high-density SNP microarrays. sCNV were estimated
using smoothed logR ratio’s of adjacent markers at 32,711 evenly
spaced loci through the genome (Methods). In the TU samples
evidence of frequent amplification or deletion involving large
genomic regions was seen (Figure 4). In contrast very few such
events were observed in the AN samples with this analysis (4 AN
samples were found to have limited evidence of copy number
variation). sCNV variation was compared to gene variation in
both the AN and TU samples.
Consistent with previous studies of other cancer types and
radiation hybrids [4,21,22,23], strong positive correlations be-
tween genes and sCNV markers were identified in cases where the
corresponding genes overlapped or were near the sCNV marker
being tested, referred to here as cis-acting associations (Figure 5A
and Table S2). The most likely explanation for this observation in
TU tissue is that sCNV induce proportional changes in genes that
were proximal to the site of that sCNV. In contrast there were no
cis-acting associations between AN CNV markers and AN genes
beyond what would be expected by chance, indicating that the cis-
correlations between sCNV and expression were tumor specific.
Given this correlations to copy number variation were only
investigated using TU tissue.
Figure 1. Genes differentially connected between AN and TU tissues. A Shown is numbers of the differentially correlated genes discovered
using a meta-analysis procedure (Methods) between AN and TU tissues. For comparison the same analysis was run both in the real data and in a
permutation of the AN and TU assignments. The top panel shows the number of differential gene pairs (Y-axis) for the real data (AN vs TU, in blue) in
comparison to the permutation (red) as a function of the p value (shown as negative log10[P], on the X-axis). The number of differentially connected
genes (middle panel) and false discovery rates (bottom panel) are also shown. B To establish that the differentially correlated gene pairs resulted from
the difference between AN and TU tissue and not for example differences between individuals the same analysis was run using AN vs AN compared
to AN vs TU using the same number of samples (Methods). The top panel shows the number of differential gene pairs (Y-axis) for both AN vs TU
(blue) and AN vs AN (red) as a function of the p value (shown as negative log10[P], on the X-axis). The number of differentially connected genes
(middle panel) and false discovery rates (bottom panel) are also shown.
doi:10.1371/journal.pone.0020090.g001
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sCNV markers revealed many highly significant associations,
referred to here as trans-acting associations (see Figure 5C). Several
genomic loci were found to be associated with many more genes
than would be expected by chance, referred to here as hotspot
sCNV loci (see Figure 5C). We identified 7 hotspot sCNV loci on 7
different chromosomes that were each associated with .500 trans
genes (correlation .0.3; FDR ,0.001). The genes associated with
these hotspots were highly overlapping, suggesting that sCNV at
multiple loci coordinately drive networks of genes (Figure 5D and
Table S3). To assess whether these hotspot loci were specific to
HCC, we carried out a similar association analysis between sCNV
markers and genes in a collection of ,130 cancer cell lines (CCL)
from multiple tissue types [24](Methods). Three of the 7 hotspot loci
identified intheHCCdataoverlapsCNVhotspotsintheCCLdata.
In all three cases the same genomic locations were involved. These
data suggest that sCNV hotspots are not unique to HCC, but in fact
may occur in many tumor types and can involve similar pairs of
genomic loci and genes, perhaps driving core biological processes
critical to tumor formation and progression. Consistent with this it
has recently been reported that the structure of sCNV is frequently
shared across multiple tumor types [25]. This might suggest that the
cis and trans correlations reported here in HCC and cells in culture
may be relevant to many tumors types with shared sCNV structure.
To establish the percentage of TU gene variation explained by
any combination of sCNV markers, we constructed genetic models
using a stepwise regression procedure for each gene (Methods and
see Table S2). As a control we ran the same analysis using the
permuted data where the connection between the genes and
sCNV markers was randomized. Using the stringent cut-off of
absolute correlation .0.3 (FDR ,0.001), the amount of variance
explained by sCNV was as high as 80%. Strikingly, greater than
40% of the genes represented on the microarrays used in this study
(15,993 out of 37,585) were significantly associated with sCNV
markers, where the average variance explained amongst these
genes by the sCNV markers was 21.8%. For 3,031 of the genes
Figure 2. Differential correlations for the top 5 genes. The top 5 differentially connected genes and their differentially connected partners are
shown. Each gene is represented by a blue oval and the top 5 are indicated by the boxes. For each of the top 5 genes also indicated is the number of
differential correlations between AN and TU in total (DiffConn) and the numbers for gain (GOC) and loss (LOC) of correlation in each case. Lines
connecting genes indicates that that pair was differentially correlated between AN and TU where both LOC (blue lines) and GOC (red lines) are
indicated. Differential connections between the top 5 genes and any other gene are shown, as well as differential correlations between genes
differentially connected to the top 5. The top 5 genes were found to be differentially correlated to a highly overlapping set of partners. Shown in the
insert table (top right) is the Fishers Exact Test p value for overlap between differentially correlated gene partners for each of the top 5 genes (lower
left of table). Also shown (upper right) is the fold enrichment for the overlaps relative to what would be expected by chance. As shown a complex
web of differential correlations resulting from tumorigenesis is revealed.
doi:10.1371/journal.pone.0020090.g002
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30% their variance was explained by sCNV markers (Table 1 & 2).
Also, while cis-acting associations explained most of the sCNV
associations, 6.6% of the genes (n=2,490) had variance explained
by sCNV markers that were other than cis, and a subset of genes
(7.8%, n=2,974) were found to have variance explained by more
than one and up to five sCNV markers on different chromosomes.
As shown above (see Figure 5) the majority of trans genes associate
with a limited number of hotspots suggesting that variation at these
limited number of loci was causing a significant proportion of the
TU gene variation. These genetic effects on tumor gene expression
are orders of magnitude larger than effects induced by germline
DNA variation.
Differentially correlated genes preferentially associate
with sCNV markers in TU
To explore whether sCNV was driving coherent changes in
networks that in turn induced phenotypic changes in the tumor, we
tested for relationships between sCNV markers and differentially
correlated genes between the AN and TU tissues. The differentially
correlated genes were significantly enriched for genes associated
with sCNV markers in cis (2.36-fold enriched; p,1e-300) as well as
for the amount of variance explained (2.12-fold enriched, p,
1e-300) and for the number of markers (1.89 fold enriched, p,1e-
300) in the regression model. This enrichment held for GOC genes
(cis 1.49 fold enriched, p=1.03e-11, variance explained in
regression model 1.55 fold enriched, p=3.48e-25, number of
markers 1.38 fold enriched, p=1.04e-18) as well as LOC genes (cis
2.17-fold enriched, p,1e-300, variance explained in regression
model 1.91-fold enriched, p=1.1e-321, number of markers 1.81
fold enriched, p=2.5e-287). The appearance of differential
correlations in HCC therefore appeared to be largely explained
by the effect of sCNV in TU tissue.
Prediction of survival in AN and TU tissues
We next characterized the relevance of the massive changes
in gene networks to the clinical course of the disease by
comparing the network changes to the subset of genes that
Figure 3. Differential correlations and connectivity structure between AN and TU tissues. To illustrate both loss and gain of correlation
two cell cycle genes were chosen that have many differential connections: the cyclin dependent kinase inhibitor CDKN2C (A, 149 loss and 11 gains of
connectivity) and the chromatin licensing and DNA replication factor CDT1 (B, 0 loss and 38 gains of connectivity). The expression intensity values for
CDNK2C (X-axis) and DCN (Y-axis) are shown (A) in AN (blue, cc 0.548, p=2e-20) and TU tissues (red, cc -0.358, p=7.14e-10). The intensity values for
CDT1 (X-axis) and MCM3 (Y-axis) are shown (B) in AN (blue, cc-0.153, p=0.0166) and TU tissues (red, cc 0.673, p=3.05e-38). Shown in C is the degree
distribution for the 8,736 differentially connected genes as described in the text. The numbers of differential connections for each gene (log10, X-axis)
was compared to the count (log10, Y-axis). As shown the distribution was scale-free, indicating that the identified genes tend to preferentially attach
to a small number of hub genes in either tumor or adjacent normal tissues, but not in both.
doi:10.1371/journal.pone.0020090.g003
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AN and TU tissues using a Cox regression model (Methods, see
Table S2). Approximately three times as many prognostic genes
were found in AN (p,0.0112, n=5,387; FDR ,0.1) versus TU
(p,0.002, n=1,836; FDR ,0.1). Although the predictive genes
in AN and TU overlap more than would be expected by chance
(1.52 fold enrichment, p=6.8e-19, representing 7.4% and
21.8%, respectively, of the AN and TU predictive genes), there
were many cases of genes highly predictive in one tissue but not
in the other. For example, of the 5,387 genes predictive in AN,
4,987 (92.6%) were not predictive in TU, and of the 1,836 TU
predictive genes, 1,436 (78.2%) were not predictive in AN, using
the above cut-off criteria (see Figure 6A). In both cases our
statistical power was 45% to detect genes predictive in one tissue
that were identified as predictive in the other tissue (Methods),
indicating that the minimal overlap was not a consequence of
low statistical power.
Genes predictive of outcome in AN and TU were
enriched for differential correlations and association to
sCNV markers
Using the AN genes predictive of survival (henceforth referred
to as AN-survival genes), almost half (2,646 of 5,387, 49%) were
found to be differentially correlated in the transition to tumor,
which is 2.11-fold greater than would be expected by chance
(p,1e-300). The AN-survival genes were also more likely to be
correlated to sCNV in cis (1.36-fold enrichment, p=1.38e-47),
and to have a higher proportion of their variance explained by
sCNV (1.32-fold enrichment, p=3.94e-50) and by a larger
number of sCNV markers (1.33-fold enrichment, p=1.09e-53)
in the regression model. Similarly genes predictive of survival in
TU tissue (henceforth TU-survival genes) were enriched for the
differentially correlated genes (1.33-fold enrichment, p=3.5e-15),
and for correlating to sCNV markers in cis (1.22 fold enrichment,
p=5.66e-8). TU-survival genes were not found to be significantly
enriched for the total variance explained or the number of markers
in the regression model.
The AN-survival genes reported here significantly overlap those
previously reported for AN-tissue in HCC [26]. and this
independent set was also enriched for differentially connected
genes (1.79-fold enrichment, p=1.7e-14), GOC genes (2.23-fold
enrichment, p=2.14e-9), and LOC genes (1.77-fold enrichment,
p=1.2e-11), demonstrating a degree of consistency among the
observations in the two studies. Given the above analyses, it is
clear that the large scale rearrangements associated with
tumorigenesis in HCC were connected to clinical outcome.
If the transformation in predictive values was mediated by
sCNV then, for example, AN-survival genes should be excluded
from correlation to sCNV markers that were themselves
predictive of survival (Table S4). This was in fact found to be
the case after adjustment for the non-random distribution of
gene:sCNV associations (fold enrichment 0.88, p,1e-300,
Methods). In contrast genes that were predictive of survival in
TU were enriched for associating with sCNV markers that were
also predictive of survival (3.37 fold enrichment, p,1e-300).
Therefore, this leads to a model (see Figure 6B) where sCNV in
TU alters the expression of genes resulting in both differential
correlations between genes as well as gain (TU-survival
genes) or loss (AN-survival genes) of prediction of disease
outcome.
Figure 4. Copy number aberrations in HCC tumor samples on chromosome 1. Shown is a heat map of copy number aberrations (sCNV) for
tumor derived samples (Y axis) clustered by K means into 10 groups, versus the linear positions through chromosome 1 (X axis). sCNV was estimated
as described in methods and is indicated as a continuum of color from red (amplification) to black (no change) to green (deletion). A scale for the
sCNV data is indicated on the right hand side of the heat-map (logR ratio from 1 to 21). As can be seen the majority of aberrations appeared to
involve large chromosomal sections on the scale of whole chromosome arms.
doi:10.1371/journal.pone.0020090.g004
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tumorigenesis was related to the pre-cancer state
Conceptually it is easy to understand genes predictive of survival in
TU – thesegenes represent gene networks and associated functions in
the tumor that were rate limiting for the future (from the time of
surgery onwards) progression of the disease, where that progression
involved continued evolution of the gene networks. In this scenario
the probability of future evolution of the gene networks was predicted
by the current state of the gene networks in TU tissue across the
individuals at the time of surgery. In other words, the probability of
future elimination of detrimental functions and assembly of beneficial
functions for the tumor is predicted by certain genes in the current
state and that is why they were predictive of survival.
Why genes in the AN tissue were predictive of survival and after
the process of tumorigenesis were no longer predictive, is less clear.
It has been proposed that AN-survival genes represent a so called
‘‘field-effect’’ and predict the likelihood of additional tumors arising
and therefore survival [26]. If this were the case presumably the
same field effect might have played a role in the appearance of the
current tumors as well (see Figure 6C lower box). This modified
hypothesis appears more parsimonious since invoking future tumors
is not required (seeFigure 6C). Consistent with this idea, our finding
that the AN-survival genes were significantly enriched for genes that
participate in the process of tumorigenesis (genes differentially
correlated between AN and TU tissues), suggests that indeed a
direct connection to the tumorigenesis that occurred in the tumors
in the HCC cohort was present. The direct connection is further
strengthened by the finding that the change in prediction of survival
for genes from AN to TU tissue can be explained by association to
sCNV markers as described above.
Figure 5. sCNV and expression correlations in cis and in trans. Distribution of correlations (X-axes) between genes (Y-axes) and the closest
sCNV marker (in cis) in TU (A) and AN (B) tissues. The distribution of the real data (blue solid lines) was compared to permutation of the gene to
marker connection (green dashed lines). No significant associations were seen in AN above what would be expected by chance. In TU there was a
pronounced bias to positive correlations. C. Distribution of correlations between all genes (Y-axis) and all sCNV markers, shown linearly by
chromosome location through the genome (X-axis). Chromosome boundaries are indicated by the vertical green lines and are numbered. Using a
correlation cut-off of .0.3 (p,4.7e-4, FDR ,0.02), the count of all genes (not including cis genes, green), positively correlated trans genes (red), or
negatively correlated trans genes (blue) is indicated for each marker (trans here was defined as genes and sCNV markers falling on separate
chromosomes). Several hotspots were apparent in which many genes were associated with sCNV at a particular locus, especially for regions on
chromosomes 1, 2, 6, 7, 12, 14 and 20 (see text for additional discussion). D. Genes associated with sCNV hotspots in HCC and cell lines significantly
overlap. Hotspot sCNV markers were selected by identifying regions associated with .500 genes (Pearson correlation coefficient.0.3) and then
selecting the single top marker per chromosome. The genes associated with each hotspot marker were compared (blue circles, size equivalent to
number of genes) and significant overlaps (Fishers Exact Test p,1e-6) are shown as edges connecting pairs of nodes. A similar analysis was
performed on a collection of cancer cell lines (CCL, green circles). In this case a smaller number of total genes were measured (23,404 vs 37,585), so an
equivalent fraction of the total genes (.370) significantly associated with a sCNV marker was required. The thickness of the edges connecting the
nodes represents the enrichment of the overlapping genes in comparison to that expected by chance (observed overlap divided by expected;
enrichment ,5 fold – thin line, .5 – thick lines). As shown the genes associated with hotspots were shared within datasets. For example, the genes
in HCC linked to the hotspots of chromosomes 2, 6, 12, 14 and 20 significantly overlap each other. Hotspot overlaps between CLL and HCC involving
the same genomic regions are highlighted in red (chromosomes 1, 14 and 20).
doi:10.1371/journal.pone.0020090.g005
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2 cm), the above direct connection between AN and TU tissues
may indicate that either the tumor is influencing the AN tissue or
vice versa, and it is this effect that explains the presence of AN-
survival genes. If this were in fact the case then correlations
between AN and TU derived gene variation should be present
(variation of gene(s) in the tumor directly alters gene(s) in AN).
Direct correlations between AN and TU genes is problematic
because inter-individual variation would be expected to dominate.
That is, a tumor may be most similar to the normal cells from
which it was derived, but this does not represent AN to TU
communication per se. Therefore, to focus on tumor specific gene
variation we tested for the association of AN gene variation with
TU derived sCNV markers, where the sCNV represents tumor
specific gene variation. Although we cannot exclude more subtle
effects, the number of associations found in the regression model
was not different than those found with permuted data (FDR ,1,
see Table S5).
The absence of evidence indicating direct communication
between AN and TU tissues leaves the possibility that the AN
tissue retains to a significant degree the characteristics of the pre-
tumor cells from which the tumor evolved. In this case, the
variance of genes prior to tumorigenesis (as represented by non-
cancer AN tissue) predicted the probability of tumorigenesis
occurring, but after that process had occurred (in TU tissue) the
same genes were no longer predictive (see Figure 6C lower box).
Consistent with this, once the AN network was transformed by
changes in gene-gene correlations driven by sCNV, the formerly
predictive genes would no longer be predictive (see Figure 6B).
Since the process of tumorigenesis is linked and perhaps driven by
network transformation, genes predictive of that process were also
predictive of survival.
We can derive from this hypothesis a testable prediction. If the
starting state of the gene networks is a determinant of the
likelihood of tumorigenesis occurring, then treatments that
promote tumorigenesis should selectively alter genes that partic-
ipate in the network transformation that characterizes that process.
To this end we took advantage of a genetic model of HCC
where the oncogene MET was over-expressed in the livers of mice,
resulting in a large increase in the numbers of HCC tumors for
that strain [27]. The hypothesis above predicts that a treatment
that promotes HCC tumorigenesis (MET overexpression), should,
prior to the onset of tumorigenesis, selectively alter genes that
participate in the network transformations associated with
tumorigenesis. The microarray profiles of liver tissues derived
from strains of mice that differed only in the presence (TRE-MET)
or absence (LAP-tTA) of overexpression of the human MET
oncogene at a time point prior to the appearance of tumors were
generated and analyzed (Methods). The resulting pre-cancer liver
MET signature (n=3,873, ANOVA p,0.01, FDR,0.01, listed in
Table S2) was found to be enriched for genes differentially
connected in human HCC (1.27 fold enrichment, p=2.9e-34).
The MET signature was also enriched for the LOC genes (1.33
fold enrichment, p=2e-31) and for genes associated with sCNV
markers in cis (1.46 fold enrichment, p=2.48e-70), variation
explained by sCNV in the regression model (1.26 fold enriched,
p=3.62e-37), and the number of markers in that model (1.23 fold
enriched, p=1.03e-31). Further, the MET signature was enriched
for genes predictive of survival in AN (1.24 fold enrichment,
p=1.5e-13) and to a lesser degree in TU (1.17 fold enrichment,
p=4.1e-3). Therefore, an alteration known to cause an increased
probability of mouse HCC tumorigenesis (MET overexpression)
altered genes that were enriched in genes that participate in the
network rearrangements characteristic of human HCC tumori-
genesis, enriched for genes associated with sCNV in the tumors
and for genes predictive of survival in AN. This is consistent with
the model that the starting state of AN-survival genes predicts the
likelihood of tumorigenesis occurring.
Enrichment of differentially correlated genes and GO
terms in co-expression networks
We next constructed co-expression networks for the AN and
TU tissues, using a method successfully applied to other large
population based studies [13,16,28] (Methods), in order to place
the core set of highly significantly differentially correlated genes
between AN and TU in a more broadly defined biological context
from which they came (AN) and to where they ended up (TU). Co-
expression analysis in HCC AN and TU samples resulted in the
identification of 25 subnetworks (modules) in AN tissue and 20
subnetworks (modules) in TU. For purposes of identification, the
modules were named as colors in order of their size, where the
prefix AN- and TU- indicated whether the module was specific to
the normal or tumor tissue network, respectively (module
membership listed in Table S2).
A high level view of network rearrangements can be seen by
comparing modules in AN and TU (see Figure 7 and Table S6).
Many significant overlaps were seen indicating that the two tissues
were far from randomly organized with respect to each other.
Closer examination revealed support for the disruption and
Table 1. Summary of regression analysis for all genes onto
sCNV markers.
R2.cut-off trans+cis cis pm trans+cis pm cis
0.1225 14845 5427 1998 0
0.2 7169 2340 352 0
0.3 3031 759 100 0
0.4 878 205 31 0
0.5 195 40 5 0
0.6 28 1 1 0
Shown are the results of the regression analyses for each gene onto selected
sCNV markers as decribed in Methods. A. Distribution of variance explained by
sCNV across all genes. Counts for number of genes with various cut-offs for
variance explained(‘‘R2.cutoff’’ column 1) for all genes and all sCNV markers
(‘‘trans+cis’’, column 2) and for cis markers only (‘‘cis’’, column 3) using the real
data was compared to a similar analysis where the connection between the
expression and sCNV markers was permuted (‘‘pm_trans+cis’’ and ‘‘pm_cis’’,
columns 4 and 5).
doi:10.1371/journal.pone.0020090.t001
Table 2. Distribution of number of genes by number of
markers in model.
No markers genes pm
1 12592 2278
2 2974 202
3 395 25
.33 2 3
In addition the distribution of genes as a function of the number of markers
included in the regression model is shown. The number of markers (‘‘no
markers’’, column 1), was compared to the number of genes with that number
of markers (‘‘genes’’, column 2) for the real data and identically processed
permuted data (‘‘pm’’, column 3).
doi:10.1371/journal.pone.0020090.t002
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ential correlation data. For example, the genes in the largest
module in AN (AN-turquoise) significantly overlapped the genes in
eight different TU modules as well as genes that could not be
placed in the TU network (referred to here as the TU-grey
module), consistent with disruption of the AN-turquoise module.
Similarly, genes in the largest module in TU (TU-turquoise),
overlapped genes in 10 AN modules as well as genes in AN-grey,
consistent with the creation of TU-turquoise as part of HCC
tumorigenesis.
Consistent with the above interpretation of the AN and TU
module overlaps was the finding that the differentially correlated
genes were enriched in many of the modules. For example, 22 of
the 25 AN modules and 13 of the 20 TU modules were enriched
for genes containing differentially correlated genes, indicating that
a majority of the subnetworks in the AN tissue representing many
different biological functions (see below and Table S8) were
disrupted as a result of the formation and progression of the
tumor, resulting in a higher level re-organization (Table S7 A&B).
To assess possible biological functions represented by the
networks, each module was tested for over-representation of genes
from individual gene ontology categories. Given the large scale re-
organizations between AN and TU, GO terms that were most
significantly enriched for each module compared to all other
modules were defined (Table S8). The purpose of this was to begin
to define biological pathways that were uniquely disrupted in AN
tissue and uniquely created in TU tissue (uniquely meaning that
the enrichment was specific to a given module). Examples of this
Figure 6. Relationship between genes in AN and TU and prediction of survival. A. Shown is the significance of association (as negative
log10 of the Cox regression p value) found between all 37,585 genes in AN (X axis) and TU (Y axis) and survival. Genes found to be significantly
associated with survival (FDR,0.1, Methods) are indicated in AN (green dots), TU (red dots) or both AN and TU (purple dots). As described in the text
most genes predictive in one tissue were not predictive in the other. B. Shown is a representation of the network transformations associated with
HCC tumorigenesis (transition from pre-tumor state, upper box, to the tumor state, lower box), where predictive genes in AN (green) largely lose their
association to survival in TU following association to non-predictive sCNV. In contrast genes predictive of survival in TU (red) are largely not predictive
in AN, and were preferentially associated with sCNV markers that were also predictive. Not shown are genes predictive in both AN and TU, and genes
not predictive in either tissue. C. Shown diagrammatically is the ‘‘Field-effect’’ hypothesis as proposed [26] (upper box), where adjacent normal genes
predict patient survival because they reflect a milieu (field-effect) in which future tumors are more or less likely to arise. In this model the current
tumors do not have a large impact on outcome whereas future tumors do. A modification of this hypothesis is proposed here (lower box), where the
adjacent normal genes represent a state that directly affected the probability of the current tumors arising and progressing. In this modified
hypothesis survival or death is mediated by the current tumors. See text for additional discussion
doi:10.1371/journal.pone.0020090.g006
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enriched in the TU-grey60 module (‘‘cytosolic ribosome’’, 113.95
fold enrichment), and aspects of macrophage function were
uniquely enriched in the AN-coral module (‘‘regulation of
macrophage differentiation’’, 83.62 fold enrichment; see Table
S8). In both cases these terms were not enriched in any other
module of either tissue. Many unique or relative enrichments of
GO terms were found for 14 of the 25 AN modules and 12 of the
21 TU modules representing a broad array of biological functions
coherently represented in the networks and altered between tissues
in HCC tumorigenesis.
Towards the identification of TU specific functions, rate
limiting for progression
Although there were many cases of GO terms uniquely
enriched in TU modules, the functional significance of this
remains to be determined. To this end enrichments of the AN-
survival and TU-survival genes in all AN and TU modules was
assessed (see Table S7 and Figure 7). The AN-survival genes were
enriched in 9 of the 25 AN modules. Given the apparent
independence of modules with respect to each other this suggests
that multiple parallel networks must be altered in the tumor and as
argued above, this is intimately linked to disease progression.
In the TU case 4 modules (TU-grey60: 9 fold enrichment, TU-
lightgreen: 6.9 fold enrichment, TU-lightyellow: 5.6 fold enrich-
ment and TU-red: 5.8 fold enrichment) were markedly enriched
for TU-survival genes (see Table S7), suggesting they were
important factors in disease progression. As judged by GO term
enrichments these modules represent distinct biological functions
including the ribosome (TU-grey60), aminoacyl-tRNA biosynthe-
sis, ribosome biogenesis and the nucleolus (TU-lightyellow) and
xenobiotic, amino acid and fatty acid metabolism, gluconeogenesis
and mitochondrial proteins (TU-red).
Ribosome components have been clearly implicated in tumor
initiation and progression in numerous cancer types [29]. In
particular it has been argued that altered translation facilitates
expression of many proliferation associated genes and may also
regulate the endothelial to mesenchymal transition which is
thought to be important in invasion and metastasis. The
enrichment of TU-survival genes in TU-grey60 and TU-light-
yellow suggests that translation and ribosome biogenesis were
selected for alteration during tumorigenesis (both modules were
enriched for genes correlated to sCNV hotspots, see Table S9), but
remained rate limiting factors in progression. Particularly
interesting is the finding of a protein complex involving DHX9,
HNRPM, LSM2, HNRNPU and SNRPD1, 2 members of which
(DHX9, HNRNPU) stabilize Myc mRNA [30] which was also a
member of the TU-lightyellow module. Myc has also been shown
to regulate ribosome biogenesis and translation and directly
interacts with multiple ribosome components suggesting a
feedback loop that may be important in cancer [31] and perhaps
captured in the TU-grey60 and TU-lightyellow modules. Targeted
interference in translation or ribosome biogenesis has been
suggested as an efficacious therapy in other tumor types and
should be explored as a therapy for HCC.
The TU-red module contains genes involved in a variety of
metabolic functions many of which occur in the mitochondrion.
Consistent with this a set of nuclear encoded mitochondrial genes
Figure 7. Overlaps between AN and TU derived co-expression modules. Co-expression modules were derived from both the AN and TU
tissues (see Results and Methods) and are represented here as circles. Green (top) and red (bottom) circles are modules derived from AN and TU
tissues respectively. The size of the circles indicates the number of genes in each including less than 100 (small), 100–500 (medium) and greater than
500 (large). Genes which were variant within the tissues but did not fall within a co-expression module are collectively represented by diamonds (one
for each tissue). The largest modules from each tissue (AN-turquoise and TU-turquoise) are indicated by the boxes. Co-expression modules in AN
(top) or TU (bottom) that were enriched for AN-survival genes (green arrows) or TU-survival genes (red arrows) are indicated. Additionally the
concentration of cell cycle genes in the TU-salmon module is indicated.
doi:10.1371/journal.pone.0020090.g007
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p=4.3e-41). Mitochondrial genes as a whole were enriched for
becoming differentially correlated in TU (1.48 fold enrichment,
p=2.7e-30) and for becoming correlated to sCNV in cis (1.72 fold
enrichment, p=5.3e-62). Mitochondrial genes were also enriched
in AN-survival genes (1.66 fold enrichment, p=9.1e-24) likely
indicating that network transformation involving this set was
linked to disease progression. The mitochondrial set as a whole
were not enriched for TU-survival genes, but perhaps significantly
those present in the TU-red module were unusual in that they
were predictive both in AN and TU tissues (16.89 fold enrichment
of genes predictive of survival in both AN and TU, p=3.5e-87).
This suggests that formation of the TU-red module was important
at both early and later stages of tumor development, and that this
is centered on a subset of mitochondrial genes.
It has been reported that a high fat diet in a genetically
susceptible background induces HCC in mouse [33], and that
obesity and metabolic disorders are risk factors for HCC
susceptibility and prognosis [12,34]. Interestingly the signature of
a high fat diet in mouse liver was enriched in the TU-red module
(2.88 fold enrichment, p=5.84e-12) linking environmental risk
factors with a molecular network predictive of survival and
biologically relevant to metabolic disease.
Discussion
Copy number aberrations are widely observed in solid tumors
and are likely the result of altered fidelity of DNA replication,
repair, checkpoints and/or chromosome segregation. These
processes leading to sCNV are by their nature intrinsic features
of cancer cells and occur in an undirected manner in terms of
chromosome location and direction of change (amplification
versus deletion). Since generation of sCNV is ongoing and will
lead to neutral, increased, or decreased fitness of the correspond-
ing cell in its environment, different derivatives will have
consequently different abilities to grow and survive, therefore
leading to evolution of the tumor over time [6]. Clinically relevant
tumor samples are therefore likely to represent the cumulative
result of undirected generation of variance (random) followed by
selection (non-random).
Using HCC and adjacent normal liver samples we investigated
the gene and sCNV changes associated with tumorigenesis by
comprehensively discovering the significant relationships within
and between DNA copy number variation, global gene expression
in TU and AN tissue and patient survival (See Figure 8 for global
summary). Analysis of these data revealed the appearance of
highly significant network changes as shown by gene pairs
differentially correlated between AN and TU tissue. Interestingly
this process largely consisted of loss of correlation in the TU
samples consistent with disruption of normal networks. A subset of
the changes observed involved gain of correlation in TU indicating
the formation of new networks in some cases. Consistent with the
view that loss of connectivity may represent loss of functionality
and gain of connectivity may be gain of functionality, the LOC
subset of genes was enriched for genes involved in normal liver
function that might be expected to be largely extraneous to the
needs of the tumor, whereas the GOC subset of genes is enriched
in the essential tumor function of cell cycle. This appearance of
loss and gain of connectivity during tumorigenesis may therefore
be analogous to the long established concepts of tumor suppressers
and oncogenes. Given the relative abundance of LOC versus
GOC events this implies that tumorigenesis in HCC at least is to a
large degree one of disruption of tumor suppressing normal
networks. Although smaller in number the GOC genes likely
represent functions selected as important for disease progression
and as such may be important points of intervention (see also
below).
Genes in TU were found to be strongly associated in cis and in
trans with sCNV frequently involving large chromosomal regions.
Within the architecture of sCNV-to-gene associations a number of
hotspots were found where many more genes were associated with
a particular marker than would be expected by chance.
Additionally the genes associated with the hotspots were highly
overlapping suggesting that multiple different loci may coordi-
nately regulate a core subset of genes. The finding of hotspots in
cancer data may not be unique to HCC in that similar
associations, even involving the same genes and sCNV loci were
found in an independent collection of cancer cell lines. Given the
common architecture of sCNV across many tumor types [25], the
cis and trans correlations documented here may therefore be
relevant to a broad range of diseases. The differentially connected
genes between AN and TU tissue were also significantly enriched
for association to sCNV markers in TU suggesting that the
network transitions and associated functional changes may be
mediated by somatic sCNV.
A surprising finding in this study was that at the same FDR,
three times as many genes predictive of survival were found in AN
than in TU tissue. Furthermore, although the AN-survival and
TU-survival genes overlapped more than would be expected by
chance, the majority of genes in each case were not predictive in
the other tissue. A direct connection between the altered predictive
value of the genes in AN and TU was found by association to
sCNV markers where AN-survival genes were preferentially
associated with sCNV markers in TU that were not predictive,
and TU-survival genes were enriched for association to predictive
sCNV markers. It therefore seems that the sCNV in tumors may
be sufficient to explain the transformation of the predictive value
of genes in AN versus TU.
To directly address the hypothesis of whether the pre-existing
state of genes that participate in network rearrangements are a
determinant of the probability of that transformation occurring,
we measured the transcriptional signature of a treatment that
promotes HCC tumorigenesis. Human MET overexpression in
mouse liver produced a gene signature, prior to the appearance of
tumors, that was significantly enriched in the human AN-survival
genes, in genes that participate in human HCC network changes,
and in genes associated in human HCC with sCNV. This is
directly supports the hypothesis that the pre-tumor state, as
measured by the AN tissue, was a significant determinant of the
large scale network transformations required to produce HCC
tumorigenesis.
There are a number of interesting ideas that derive from this
hypothesis. One is that MET overexpression causes increased
tumorigenesis by altering the genes (networks) that participate in
that transition, or in other words the starting state of these genes is
causally related to the probability of the future transformation
occurring. Similarly then, the starting state of the AN-survival
genes may be causal for the probability of network transformations
involving them in human HCC. The TU-survival genes in an
analogous manner may also be causally related to the probability
of future network evolutions relevant to disease progression. This
further suggests, that as in the MET case, manipulation of the
relevant genes will alter the probability of HCC network changes
and tumor evolution occurring.
The finding that AN-survival genes for the most part lose their
predictive value in tumor is interesting. By implication once the
network transformation has occurred those genes and their
associated functions were generally no longer rate limiting. This
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(LOC genes) and creation of new networks (GOC genes). From a
perspective of targeting tumors, disruption of normal networks
may be hard to reverse in practice. However the creation of new
networks may represent functions that the tumor has gained or
emphasized relative to the tissue from which it was derived. As
such these functions may make desirable targets in that the tumors
have selected for them and the selection process may relate to
Figure 8. Global distribution of survival associated genes and sCNV, differentially connected genes and gene-sCNV correlations.
Shown is a high level summary of various relationships described in this work. The graph was assembled using the Circos software (http://mkweb.
bcgsc.ca/circos/) and data in Tables S2 and S4. Genomic positions are indicated on the outer circle with both chromosome (large numbers) and
nucleotide position (smaller numbers, x1,000,000 nt) as indicated. The bars on the outer circle indicate the positions of cytobands. The 2
nd (green
background) and 3
rd (red background) circles indicate the genes (by chromosomal location) that predict survival in AN or TU tissues respectively
where a longer line indicates greater significance (see Table S2 and text). The 4
th circle (yellow background) indicates genes found to be differentially
correlated between AN and TU tissue where the length of the line is proportional to the log10 of the number of differential correlations for that gene
(see Table S2 and text). The 5
th circle (dark blue background) shows sCNV markers that predict patient survival where a longer bar is more significant
(see Table S4 and text). The 6
th and innermost circle (light blue background) shows the number of genes correlated to each sCNV marker (cis and
trans correlations, see Table S4 and text).
doi:10.1371/journal.pone.0020090.g008
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essential tumor specific functions.
Finally, TU-survival genes may also represent an opportunity
for intervention in that as described above they may causally relate
to the probability of future disease progression. Investigation of co-
expression networks highlighted 4 co-expression modules that
were enriched for TU-survival genes. Two of the 4 modules were
strongly linked to ribosomes and ribosome biogenesis, which have
been linked to aggressive disease in other tumor types and
individual components when either over or under expressed
promote tumorigenesis. Myc has been shown to alter a number of
ribosome components and in turn can be regulated by them and
was found here to be in the same co-expression network. This
suggests that altered translation maybe a significant factor in HCC
disease progression. A third co-expression module was unusually
found to be enriched for both AN and TU-survival genes and
centered around metabolism and the mitochondrion. Although it
is speculation it is tempting to suggest that this group of genes may
represent the molecular equivalent of the epidemiological
observation that obesity is a risk factor for susceptibility to HCC
and survival after diagnosis. Interestingly it was recently suggested
that switching to a low fat diet alters the course of disease in mouse
models.
Materials and Methods
Patient demographic and clinical parameters
Demographic and pathologic parameters for the 272 ethnic
Chinese HCC patients who received curative surgery and used in
this study are shown (see Table S1, see also [17]). Half of the
patients (51.1%) suffered from tumor recurrence during the follow-
up period. The primary endpoints measured were overall survival,
disease-free survival (DFS), and tumor stage (pTNM [35]). In a
simple Cox model, the endpoints were found to be significantly
associated with tumor size, serum alpha fetoprotein (AFP) levels,
total albumin concentration (ALBU), venous infiltration (veninv),
AJCC stage [35], and the number of tumor nodules (NOTN).
Patient and ethics approval for this study was obtained from
Institutional Review Board of the University of Hong Kong/
Hospital Authority Hong Kong West Cluster (HKU/HA HKW
IRB).
Sample processing to isolate DNA and RNA
Tissue milling and division was accomplished as follows. Flash
frozen tissue was placed in a chilled milling tube along with a
stainless steel bead, dipped in a liquid nitrogen bath and loaded
onto the QIAGEN TissueLyser for milling (30 Hz in 30 second
intervals). Multiple cycles of milling were sometimes required to
achieve complete pulverization of the tissue to a fine powder. After
milling, the tissue powder was recovered and rapidly manually
split for extraction of DNA and RNA. At all times sub-zero
temperatures were maintained.
Homogenous tissue aliquots resulting from the milling process
were digested overnight with proteinase K. A portion of the digest
was then dedicated to DNA extraction using an automated
protocol based on the Agencourt (Beverly, MA) Genfind SPRIH
(Solid Phase Reversible Immobilization) paramagnetic bead-based
technology for the selective immobilization of nucleic acids onto
magnetic microparticles. Following the precipitation of the eluted
DNA, samples were quantitated using PicoGreen (Invitrogen) and
qualified by agarose gel electrophoresis.
Isolation of RNA was achieved using the following procedures.
The milled tissue samples were homogenized in cryopreservation
tubes with a vortex mixer after addition of 750 to 1000 uL of
100% TRIzol. 100% Chloroform was added to the TRIzol/
GITC lysate (1:5 ratio) to facilitate separation of the organic and
aqueous components using the phaselock (Eppendorf) system.
The aqueous supernatant was further purified using the Promega
SV-96 total RNA kit, incorporating a DNase treatment during
the procedure. Isolated total RNA samples were then assayed for
quality (Agilent Bioanalyzer) and yield (Ribogreen) metrics prior
to amplification.
RNA amplification and hybridization
Samples were amplified and labeled using a custom automated
version of the RT/IVT protocol and reagents provided by
Affymetrix. Hybridization, labeling and scanning were completed
following the manufacturer’s recommendations (Affymetrix).
Sample amplification, labeling, and microarray processing were
performed by the Rosetta Inpharmatics Gene Expression
Laboratory in Seattle, WA.
Gene expression data processing
The intensity of all gene array experiments were normalized
together using the RMA method [36]. Afterwards, the intensity
was adjusted for gender and age of the patients. To avoid the
influence of outliers, we fitted the robust linear model (rlm, M-
estimation with Tukey’s bisquare weights, implemented in R
statistical package), and used the residuals as the gene trait in all
subsequent analyses. In brief, for every gene (for example, genej)
we fitted a linear model:
Expressionij~ b0 z b1Agei z b2Genderiz rij,
where Expressionij is the expression level for genej in the i
th
patient; and Agei and Genderi are age and gender of the i
th
patient. Each patient contributes to the model differently
according to his/her Tukey’s bisquare weights derived from rij.
The expression data has been deposited in GEO (GSE25142,
http://www.ncbi.nlm.nih.gov/geo/).
DNA genotyping
Whole genome genotyping was performed using the Illumina
Infinium Assay, following all manufacturer specifications. Approx-
imately 750 ng of high molecular weight genomic DNA was used
for each sample to produce genotyping calls across 650,000 SNPs
distributed throughout the human genome. The technology used
was reported [37], and current protocols are available from www.
illumina.com. To identify copy number variation, we obtained the
log R ratios and smoothed the data using a 40-SNP window with a
20-SNP step to minimise noise and maximise signal. The
genotyping data has been deposited in GEO (GSE28127,
http://www.ncbi.nlm.nih.gov/geo/).
Enrichments tests for gene sets versus Gene Ontology
(GO) and other terms
The gene sets as defined in the text were compared to
independently derived collections of genes representing biological
functions in various public and other databases using the Fisher
Exact Test. The p values in all cases represent the significance of
the Fisher Exact Test statistic under the null hypothesis that the
frequency of the indicated gene set is the same between the
network module and the reference set of genes taken to be the set
of genes comprising the network of interest. Given many such tests
were performed over many gene sets, a conservative Bonferroni
adjustment for multiple testing was employed by multiplying the
resultant p values by the number of tests performed.
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represented in co-expression modules the following procedure was
used. As above enrichments of GO term for each co-expression
module was assessed using Fishers Exact test and corrected for
multiple testing by multiplying the p values by the number of tests.
An adjusted p,0.05 was used as a cut-off. Fold enrichments
(observed overlap divided by expected), were then used to
compare enrichments of individual GO terms between modules.
What is shown in Table S8 are cases where a GO term was more
highly enriched (fold enrichment) in comparison to all other
modules.
Meta-analysis of gene-gene correlation
For each gene pair (i,j) and their Spearman correlation
coefficients, rtij, where t= {tumor,normal} is measured in tumor
and adjacent normal tissues, respectively, we first transformed the
correlation coefficients into Fisher’s Z-statistics:
ztij~
1
2
log
1zrtij
1{rtij
  
which follows a normal distribution with mean zero and standard
deviation of 1  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
nt{30 p , where nt is sample size. A heterogeneity
statistics, Q, is then computed as follows
Q~
X
t
wt(zt{  z z)
2
where wt=n t23 and   z z is the average z between tumor and
adjacent normal tissues. Under the homogeneity assumption, the
Q statistics should follow a x
2 distribution with one degree of
freedom under the homogeneity assumption. The larger the Q
statistic is, the less similar the two gene’s relationship is between
the two tissues. We chose Q0=80, corresponding to a p-value of
p0=1|10
220, as the cutoff to determine the statistical significance
of the heterogeneity Q statistic. Gene pairs with Q.Q0 were
considered as significantly differentially connected and were
retained for subsequent analysis. We further estimated that the
false discovery rate at our selected cutoff was FDR ,1|10
26 by
repeating the same meta-analysis procedure on a permuted
version of the original data in which the sample labels were
randomly assigned.
DNA/gene associations and permutations
For DNA/mRNA associations, smoothed logR ratio’s were
derived by taking the average intensity for 40 adjacent markers
sequentially through the genome with a step size of 20 markers.
This procedure results in 32,711 sCNV markers evenly distributed
through the genome. The degree of DNA association to mRNA
was measured by using Pearson correlation coefficient on the
smoothed log R ratio data in a pair-wise fashion, using gene
expression, adjusted by gender and age as described above. Cis
effects were defined as the closest DNA marker within 5 Mb of the
gene encoding each mRNA. The significance of DNA/mRNA
correlations, was assessed by permuting the sample assignments
such that the connection between the two data types is destroyed
but the connections with each type (DNA/DNA and gene/gene)
are maintained.
The smoothed logR ratio procedure was compared to a
published segmentation method [38] which is reported to be
comparable to other published methods [39], by assessing the
number of significant associations between copy number variation
(as defined by each method) and expression variation in cis for a
given FDR. In a head to head comparison the smoothed logR
ratio method discovered larger numbers of cis associations at all
FDR cut-off’s in comparison to the published method (see Table
S10). In light of this the smoothed logR ratio method was used for
all estimations of copy number variation.
As described in the text certain loci are associated with
hundreds of genes. Using an arbitrary cut-off for markers
associated with .500 genes (correlation .0.3), 7 loci were
identified as described in the text. To assess if these ‘‘hotspots’’
could have occurred by chance the connection between the gene
expression and sCNV data was permuted while maintaining the
internal structures of expression and DNA variation. After 10 such
permutations no hotspots were discovered using the criteria above,
therefore we concluded that the observed hotspots were not likely
to have occurred by chance.
Stepwise regression to quantify sCNV contribution to
mRNA variation
A forward stepwise multi-linear regression model was used to
derive the adjusted squared regression coefficient (r2) for the
proportion of mRNA variance accounted for by sCNV at multiple
loci. For a given mRNA, we first fitted the initial model with the
most correlated sCNV marker (p value cut-off =5.1e-6, 0:35 jj ),
and then added another predictor from a different chromosome
and compared the RMSE (mean squared error) of the new model
to the previous one. If the new model had a smaller RMSE (mean
squared error), then it was added to the model. This was repeated
until no further improvement for the model was seen.
Identifying expression traits and sCNV markers
significantly associated with clinical endpoints
To explore the connections between sCNV markers, expression
variation and disease endpoints, we identified those traits detected
as most highly associated with survival in AN or TU tissue using a
simple Cox regression model. In all cases a false discovery rate of
0.1 was derived from 100 permutations of the data. This resulted
in 1,836 genes (p,0.002) and 3,223 sCNV markers (p,0.0089) in
TU and 5,387 genes (p,0.0112) in AN tissue associated with
survival.
Enrichment of AN and TU-survival genes for association
to sCNV markers
To adjust for the non-random distribution of significant
associations between genes and sCNV markers through the
genome, the following adjustment was made. For each sCNV
marker the expected number of associations was derived by
multiplying the test gene set (AN or TU-survival genes) by the total
number of genes associated with that marker for a given cut-off
and then dividing by the total number of genes measured
(n=37,585). This expected value was then used to divide the
observed number of genes for the test gene set for the sCNV
marker in question (i.e.observed divided by expected). The
resulting ratio’s were then used to assess the relative enrichment
of AN and TU-survival genes for association to sCNV markers
that were or were not predictive of survival as defined above.
Description and analysis of cancer cell line (CCL) data
CCL cohort description. 131 cancer cell lines from Caucasian
donors were used in this study which has been more fully described
elsewhere [24]. These cell lines were derived from various tumor
tissues (31 colon, 26 leukemia/lymphoma, 20 lung, 15 skin, 6 breast,
6 bladder, 5 pancreas, and 22 from other tissues like stomach, brain,
prostate, cervix, bone, liver, tongue, and uterus).
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Inversion Probe) platform [40] was selected to identify copy
number variations in these cell lines. Approximately 8 ug of
genomic DNA from each of the human tumor cell lines was
extracted from cultured cell lines. A total of 17,000 SNP markers
were genotyped using the MIP platform. Derivation and
normalization of copy number for each markers was performed
exactly as described [40]. To reduce the noise, copy number data
for each marker was smoothed using adjacent markers (markers
located 300 kb up or down-stream) [40].
CCL mRNA Expression data. Labeled cRNAs from mRNA
samples obtained from the cell lines were fragmented to an
average size of approximately 50 to 100 nucleotides then
hybridized to Agilent Human 3.0 A1 arrays. Fluorescence
intensities of the scanned images were quantified, normalized,
and balanced and then gene expression (mlratio) was measured
relative to a common reference RNA pool (Human Universal
Reference RNA, Stratagene, La Jolla, CA), by using Rosetta
Resolver Agilent Error Model. This data has been loaded into
NCBI GEO database, with accession number GSE13598: (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13598).
CCL Tissue/cancer type effect on sCNV. To assess the
presence of tissue/cancer type effect on sCNV, we first assigned
each cell line to one of the eight tissue types of origin based on
available annotations, then ran a one-way ANOVA analysis on
every marker. Permutations were done by randomizing the tissue
assignment. Finally the original sCNV markers were adjusted by
tissue means to normalize the tissue effect. The same process was
used to adjust mRNA expression data.
CCL DNA/mRNA associations and permutations. The
degree of DNA/mRNA association was measured by using
Pearson Correlation Coefficient on log2 transformed, tissue-
adjusted copy number data in a pair-wise fashion. For cis-acting
effect, we matched mRNA’s probes on the expression arrays with
the closest DNA copy number marker within 5 Mb. To assess the
significance of DNA/mRNA correlations, we did the same
analysis on permuted datasets, in which the links between sCNV
and their original cell lines were randomly shuffled. Since this
study focused on relationship among unlinked sCNV, when
permuting the DNA copy number data, we preserved intra-
chromosomal marker correlations.
MET mouse liver signatures
The mice used in this study have been described [27]. All mice
were in the FVB genetic background. The mice overexpressing
human MET carried one copy of the LAP-tTa transgene (the
liver-specific LAP promoter driving the Tet-VP16 transactivator)
and one copy of the Tre-Met transgene (Tet-operator regulated
human MET gene). The presence of both transgenes in these mice
results in expression of the human MET gene specifically in and
throughout the liver (referred to henceforth as the TRE-MET
strain). A strain carrying two copies of the LAP-tTa transgene only
was used as a control (referred to henceforth as the LAP-tTA
strain). Seven mice of each of the two strains were sacrificed at 6 or
7 weeks of age prior to the appearance of tumors and the livers
collected and processed for gene expression profiling (as described
above) at the Rosetta Gene Expression Laboratory. As a control
for the ability of the MET transgene to produce tumors, a parallel
set of 7 mice for each of the two strains was sacrificed after 14
weeks, where 2 or more tumors per liver were found in each of the
MET overexpressing mice and none in the control strain. MET
specific signatures were defined as genes with an ANOVA p,0.01
between the LAP-tTA and TRE-MET derived samples at 6-7
weeks of age.
Reconstruction of tumor and adjacent normal
coexpression networks
A previously described weighted gene coexpression network
reconstruction algorithm was employed to reconstruct the
coexpression networks [13,16,28]. The weighted network recon-
struction algorithm involved first constructing a matrix of Pearson
correlations between all gene expression pairs. The correlation
matrix was then transformed into an adjacency matrix using the
power function f (x)=x
b. The adjacency matrix defines the
weighted coexpression network. The parameter b of the power
function was determined such that the resulting adjacency matrix
was approximately scale-free. To measure how well a network
satisfies the scale-free topology property, we used the model fitting
index proposed by Zhang & Horvath. This index is defined as the
coefficient of determination (i.e., R
2) of the linear model
constructed by regressing Log(p(k)) onto log(k), where k represents
the degree of a given node (i.e., the number of edges connecting to
the given node), and p(k) is the frequency distribution of the degree
k in the coexpression network. The model fitting index of a perfect
scale-free network is 1. The exponent of the power function, b, was
chosen to be the smallest value such that the coexpression network
exhibited the scale free property (b=3.5 in this case). The degree
distribution of the coexpression network approximates a power
law (p(k),k
-1.36 p(k),k
-1.93), with a model fitting index .0.7.
Supporting Information
Table S1 Demographic and clinical characteristics of
HCC patients.
(XLS)
Table S2 Summary by gene. Shown are a number of
measures (columns) derived from this analysis for each gene (rows).
The columns are as follows ‘‘idx’’ is a unique row identifier,
‘‘Reporter Id’’ indicates the probe on the array; ‘‘chr’’, ‘‘pos’’ and
‘‘cytoband’’ refer to the gene location by chromosome nucleotide
position and cytoband respectively; ‘‘Symbol’’ indicates the gene
name; ‘‘Entrez’’ indicates the Entrez Id; ‘‘transcript’’ lists
commonly used transcript identifiers for each probe; ‘‘AN-
module’’ and ‘‘TU-module’’ indicate membership in co-expression
modules in the AN and TU tissue respectively; ‘‘Pval_TUvsAN’’ is
the paired t-test p value for the difference in expression between
AN and TU tissues; ‘‘Connectivity’’ indicates the total number of
differential connections (gain plus loss) as defined in the text, and
the number of gain ("#GOC") or loss ("#LOC") of correlations in
tumor; ‘‘cis_CC’’ indicates the Pearson correlation coefficient
between each gene and the closest CNV marker (in cis);
‘‘adjusted_r2’’ indicates the variance explained for each probe
using the linear regression model as described in the text and
methods; ‘‘N_Markers_in_Model’’ is the number of CNV markers
used in the linear regression model where each marker is from a
different chromosome (see text and Methods); ‘‘Pval-AN-survival’’
and ‘‘Pval-TU-survival’’ indicates the Cox-regression p value for
prediction of survival using either AN or TU expression values
respectively; ‘‘Sig-AN-survival’’ and ‘‘Sig-TU-survival’’ indicate
genes significantly predictive of survival (FDR,0.1), where ‘‘1’’=
predictive and ‘‘0’’= not predictive for AN and TU tissue; ‘‘MET-
Sig’’ indicates genes significantly altered by MET expression in
mouse liver (‘‘1’’) or not significantly altered (‘‘0’’). Please refer to
the text and Methods for fuller descriptions of the various
measures.
(XLS)
Table S3 Overlaps between genes correlated to sCNV
hotspots. Overlaps between genes correlated to the top 7 sCNV
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identified by the chromosome on which they resided (top row and
first column). The Fisher Exact test p value for the overlap is
shown for each comparison below and to the left of the grey boxes.
The fold enrichment over chance (observed divided by expected) is
shown above and to the right of the grey boxes. Fold enrichments
are not shown for non-significant overlaps.
(XLS)
Table S4 Relationship of sCNV markers to survival.
Listed are the relationships found between sCNV markers genome
wide and survival using Cox regression (Methods). ‘‘Idx’’ indicates
a unique identifier for each sCNV marker, ‘‘SNPid’’ is the SNP
identifier for the SNP at the center of the smoothed window of
adjacent sCNV markers (see Methods for derivation of smoothed
sCNV markers), ‘‘chr’’ indicates the chromosome, ‘‘pos’’ is the
nucleotide position of the middle of the smoothed with of markers,
‘‘CNV2GE_correlation’’ indicates the number of genes signifi-
cantly correlated to each sCNV marker, ‘‘NeglogP-CNV-Surviv-
al’’ shows the negative log10 of the p value for prediction of
survival using Cox regression, and ‘‘Sig-CNV-Survival’’ indicates
markers considered to significantly predict survival where ‘‘1’’ is
significant and ‘‘0’’ is not significant.
(XLS)
Table S5 Summary of linear regression analysis for AN
expression versus TU sCNV markers. The distribution of
variance explained by sCNV markers in the regression models for
all genes is shown (Methods) using AN expression and TU derived
sCNV markers.Countsfornumber ofgeneswithvariouscut-offsfor
variance explained (‘‘R2.cutoff’’ column 1) for all AN genes and all
TU sCNV markers (‘‘trans+cis’’, column 2) and for cis markers only
(‘‘cis’’, column 3) using the real data was compared to a similar
analysis where the connection between the expression and sCNV
markers was permuted (‘‘pm_trans+cis’’ and ‘‘pm_cis’’, columns 4
and 5).As shown the realdata was not significantly different that the
permuted data indicating a lack of detectable signal.
(XLS)
Table S6 Co-expression module to module overlaps
between tissues. Shown are the overlaps found between co-
expression modules derived from AN and TU tissues. ‘‘Set1’’ and
‘‘Set2’’ indicates the AN and TU modules tested respectively.
‘‘Pval’’ and ‘‘Fold’’ indicate the Fishers Exact test p value for
enrichment of overlap and the fold increase in the overlap versus
what would be expected by chance respectively. Results with a p
value ,1e-3 are shown.
(XLS)
Table S7 Enrichments of predictive and differentially
correlated genes in the AN and TU co-expression
modules. A Co-expression modules tissue, name and number
of genes in each module (columns 1–3) are indicated. The number
of GO terms enriched, and the top GO terms enriched for each
module with enrichment p value and fold enrichment are also
shown (columns 4–7) and the total number of GO terms enriched.
Enrichments of genes predictive of survival in AN and TU tissue
(columns 8–10 and 11–13, respectively), and for genes differen-
tially correlated (columns 14–16), and the gain (columns 17–19)
and loss (columns 20–22) are also shown. All p values were from
the Fishers Exact test and fold enrichment were calculated by
dividing the observed overlap by the expected overlap. B is as for
A but with modules derived from TU tissue.
(XLS)
Table S8 GO term enrichments for AN and TU co-
expression modules. Shown are the top GO term enrichments
as judged by the relative fold enrichment for each AN and TU co-
expression module. ‘‘Similar Set’’ indicates the GO term,
‘‘Module’’ indicates the co-expression module. ‘‘Fold’’ indicates
the fold enrichment of the overlap versus expected, and ‘‘Diff’’
indicates the difference in fold enrichment between the indicated
module and the next most enriched module from either AN or TU
tissue. In cases where ‘‘Fold’’ and ‘‘Diff’’ are the same, there were
no other significant enrichments for that term in any other
module. That table is ranked in descending order by the fold
enrichment.
(XLS)
Table S9 Overlaps between sCNV hotspot correlated
genes and co-expression modules. Shown are the overlaps
found between genes correlated to the top sCNV hotspots
(‘‘Hotspot’’) and co-expression modules from AN and TU tissue
(‘‘Module’’). Also indicated is the fold enrichment of the overlap
versus the random expectation in each case (Fold). Only
enrichments with a Fishers Exact test p,1e-3 are shown.
(XLS)
Table S10 Comparison of CGHseq and smoothed logR
ratio methods of estimating sCNV. Shown is a comparison
of methods for estimating copy number aberrations as described in
the Methods. The ability of each method to detect associations
between DNA variation and gene variation in cis for a given FDR
was assessed. Shown are the FDR cut-offs applied (‘‘FDR’’,
column 1), and the number of significant associations between
genes and copy number aberration in cis using the CGHseg
method (columns 2 and 3) and the smoothed logR ratio method
(column4 and 5) for the real data (columns 2 and 4) and permuted
data (used to calculate the FDR’s, columns 3 and 5). As shown the
smoothed log R ratio method appear to detect many more cis
associations for a given FDR than the CGHseg method.
(XLS)
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